Wikidata

(Q58024751)

English

BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma

No description defined

In more languages

Statements

title
BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma (English)
0 references
author name string
A. Ribas
series ordinal
1
0 references
K. B. Kim
series ordinal
2
0 references
L. M. Schuchter
series ordinal
3
0 references
R. Gonzalez
series ordinal
4
0 references
A. C. Pavlick
series ordinal
5
0 references
J. S. Weber
series ordinal
6
0 references
G. A. McArthur
series ordinal
7
0 references
T. E. Hutson
series ordinal
8
0 references
K. T. Flaherty
series ordinal
9
0 references
S. J. Moschos
series ordinal
10
0 references
D. P. Lawrence
series ordinal
11
0 references
P. Hersey
series ordinal
12
0 references
R. F. Kefford
series ordinal
13
0 references
B. Chmielowski
series ordinal
14
0 references
I. Puzanov
series ordinal
15
0 references
J. Li
series ordinal
16
0 references
K. B. Nolop
series ordinal
17
0 references
R. J. Lee
series ordinal
18
0 references
A. K. Joe
series ordinal
19
0 references
J. A. Sosman
series ordinal
20
0 references
publication date
20 May 2011
0 references
volume
29
0 references
issue
15_suppl
0 references
page(s)
8509-8509
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q58024751&oldid=1404700071"